
Mim Neurosciences is developing new treatments for neurodegenerative disease based on NAD biology
Mim Neurosciences is developing novel small molecules targeting NMNAT2; the neuron's most important enzyme for NAD synthesis. Situated within Karolinska Institutet and St. Erik Eye Hospital, we are ideally located to translate findings from bench-to-bedside.
↓
Need
Treatments that arrest neurodegeneration and are neuron-specific are the Holy Grail of neurodegenerative disease research
Meet the team
Pete Williams
Inventor, founder, owner, principal scientist
Andrea Brancale
Inventor, medicinal chemist
Lilian Wikström
Business development and management